Pharmacokinetic concerns related to the AIDS Clinical Trial Group (ACTG) A5262 trial.
Cristina
C
Gervasoni
Dario
D
Cattaneo
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D008297:Male; D011760:Pyrrolidinones / Q000627:therapeutic use*; D019438:Ritonavir / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*
D019380:Anti-HIV Agents; D011760:Pyrrolidinones; D013449:Sulfonamides; D019438:Ritonavir